No abstract

No abstract

No abstract

Many efforts are being made to find biomolecules extracted from plants to be useful therapeutic agents to replace the drugs traditionally used in clinical medicine with known side effects and high financial investment, thus offering greater safety and less risk to the population. However, the presence of toxic substances such as alkaloids, amino acids, amides, glycosides, saponins, and tannins are the main reasons for the poisonous activity of some medicinal plants. In this sense, understanding plants constituents and lethal doses can be important source in managing several diseases in human life. This review aimed to present extracts, fractions, and/or compounds of plants of Brazil and Asia regions that have reported toxicity to in vitro and in vivo models. The results presented here contribute to warning the population about the toxicological characterization of some plants, however, further high‐quality studies are needed to firmly establish the clinical efficacy of the plants (or compounds).

Introduction The COVID-19 global pandemic is a public health emergency due to its high virulence and mortality. Many vaccine development studies at clinical trials are currently conducted to combat SARS-CoV-2. Plants are a rich source of phytochemicals with different biological activities, including antiviral activities, which are the focus of many studies. Areas covered This review shows compounds of traditional plants listed on RENISUS list have therapeutic properties against SARS-CoV-2 targets. Expert Opinion The rise of new variants, more pathogenic and virulent, impacts in the increase of mortality from SARS-CoV-2 infection, and thus, the control of the outbreaks of disease remains a global challenge. Other’s drug and vaccines development is an essential element in controlling SARS-COV-2. Therefore, it is imperative that approach to tackle this pandemic has to be solidly evidence-informed. It should be noticed that the immune system does play critical roles in fighting viruses. Studies show that T cells levels decreased continuously as the disease progressed. T cell-mediated cellular immune response, probably by immunological memory, is essential for direct virus eradication after infection whilst B cells functions in producing antibodies that neutralize virus.But, have distinct patterns of T cell response exist in different patients, suggesting the possibility of distinct clinical approaches. Efforts are concentrated to elucidate the underlying immunological mechanisms in SARS-CoV-2 pathogenesis and progression for better design of diagnostic, therapeutic and preventive strategies. We seek to identify biomolecules with the potential to act in biomarkers that predict how severe the disease can get. But it is important to warn that the plants that produce the compounds mentioned here should not be used without a physician prescription. Finally, we speculate that these compounds may eventually attract the attention of physicians and researchers to perform tests in specific contexts of SARS-CoV-2 infection, and if they show positive results, be tested in Clinical trials.